Eyegate Pharmaceuticals Inc

NASDAQ:EYEG  
2.00
+0.10 (+5.00%)
Earnings Announcements

EyeGate Pharma Reports Q2 2021 Financial Results

Published: 08/12/2021 21:07 GMT
Eyegate Pharmaceuticals Inc (EYEG) - Eyegate Pharma Reports Second Quarter 2021 Financial Results and Provides Business Update.
Eyegate Pharmaceuticals Inc - Cash and Cash Equivalents Were $3.663 Million As of June 30, 2021.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.31

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.25

More details on our Analysts Page.